Absolutely. Trip 2s would cost him a meager 20K for a 100 milly buyback. Anything that improves the SS will solidify the Co. as a, still legitimate player, in this sector; which by the way, I still believe has 3-5 years before it truly explodes.
As long as we stay away from the SEC, which we have, keep the toxicity low, which we have, and re-energize with a CEO down the road, which I believe we will, plenty of opportunity still exists, IMO.
(0)
(0)
Green Cures & Botanical Distribution Inc. (GRCU) Stock Research Links